DNA - Ginkgo Bioworks Holdings, Inc. -  [ ]

Ticker Details
Ginkgo Bioworks Holdings, Inc.
IPO Date: September 17, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $549.38M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.26 | 4.56%
Avg Daily Range (30 D): $0.33 | 4.06%
Avg Daily Range (90 D): $0.34 | 4.22%
Institutional Daily Volume
Avg Daily Volume: 15.09M
Avg Daily Volume (30 D): 1.13M
Avg Daily Volume (90 D): 1.06M
Trade Size
Avg Trade Size (Sh.): 488
Avg Trade Size (Sh.) (30 D): 80
Avg Trade Size (Sh.) (90 D): 78
Institutional Trades
Total Institutional Trades: 2,322
Avg Institutional Trade: $1.75M
Avg Institutional Trade (30 D): $.82M
Avg Institutional Trade (90 D): $.9M
Avg Institutional Trade Volume: .03M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.55M
Avg Closing Trade (30 D): $.85M
Avg Closing Trade (90 D): $.9M
Avg Closing Volume: 61.59K
 
News
May 12, 2026 @ 2:30 PM
The $59B Quiet Shift Reshaping How Patients Access...
Source: Equity Insider
Apr 8, 2026 @ 8:00 PM
ProQR Highlights Pipeline Expansion and Multiple U...
Source: Proqr Therapeutics N.V.
Sep 23, 2025 @ 4:00 PM
A-Alpha Bio Appoints Troy Lionberger as New Chief ...
Source: Troy Lionberger
Mar 3, 2025 @ 6:00 PM
Global Microbial Fermentation Technology Market to...
Source: Delveinsight
Dec 5, 2024 @ 5:53 PM
Synthetic Biology Market Forecast: $61.6 Billion b...
Source: Bcc Research
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-5.36 $-1.39 $-1.42
Diluted EPS $-1.42
Revenue $141.31M $19.47M $33.4M
Gross Profit $16.38M
Net Income / Loss $-304.39M $-82.59M $-80.75M
Operating Income / Loss $-297.68M $-71.37M $-70.75M
Cost of Revenue $3.1M
Net Cash Flow $-166.74M $-23.7M $55.41M
PE Ratio    
Splits
Aug 20, 2024 1:40